Effects of exemestane or tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial: a meta-analysis

被引：0
|
作者：
Hadji, P. [1 ]
Asmar, L. [2 ]
Van Nes, J. G. [3 ]
Menschik, T. [4 ]
Hasenburg, A. [5 ]
Kuck, J. [6 ]
Nortier, H. [3 ]
Jones, S. [2 ]
Van der Velde, C. [3 ]
Ziller, M. [1 ]
机构：
[1] Univ Marburg, Marburg, Germany
[2] US Oncol Res Inc, Houston, TX USA
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Pfizer Oncol, Paris, France
[5] Univ Freiburg, Freiburg, Germany
[6] Independent Clin Res Consulting, Berlin, Germany
来源：
BREAST | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [31] Estrogen and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the tamoxifen and exemestane adjuvant multinational (TEAM) trial
    Bartlett, J. M. S.
    Brookes, C. L.
    van de Velde, C. J. H.
    Billingham, L. J.
    Hasenberg, A.
    Markopoulos, C.
    Mallon, E. A.
    Paridaens, R.
    Seynaeve, C.
    Rea, D. W.
    EJC SUPPLEMENTS, 2009, 7 (02): : 264 - 264
  • [32] Results of the first planned analysis of the TEAM (tamoxifen exemestane adjuvant multinational) prospective randomized phase Ill trial in hormone sensitive postmenopausal early breast cancer
    Jones, S. E.
    Seynaeve, C.
    Hasenburg, A.
    Rae, D.
    Vannetzel, J-M
    Paridaens, R.
    Markopoulos, C.
    Hozumi, Y.
    Putter, H.
    Hille, E.
    Kieback, D.
    Asmar, L.
    Smeets, J.
    Urbanski, R.
    Bartlett, J. M. S.
    van de Velde, C. J. H.
    CANCER RESEARCH, 2009, 69 (02) : 67S - 67S
  • [33] Quality of life in relation to hormonal treatment of postmenopausal women in the Dutch Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial
    van Nes, J. G. H.
    Voskuil, D. W.
    van Leeuwen, R. E.
    Junggeburt, J. M. C.
    de Haes, H. C. J. M.
    van de Velde, C. J. H.
    CANCER RESEARCH, 2009, 69 (02) : 69S - 69S
  • [34] PIK3CA mutations are linked to PgR expression: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) pathology study.
    Sabine, V. S.
    Crozier, C.
    Drake, C.
    Piper, T.
    van de Velde, C. J. H.
    Hasenburg, A.
    Kieback, D. G.
    Markopoulos, C.
    Dirix, L.
    Seynaeve, C.
    Rea, D.
    Bartlett, J. M. S.
    CANCER RESEARCH, 2012, 72
  • [35] Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis
    van Nes, Johanna G. H.
    Beex, Louk V. A. M.
    Seynaeve, Caroline
    Putter, Hein
    Sramek, Alexandr
    Lardenoije, Susanne
    Duijm-de Carpentier, Marjolijn
    Van Rongen, Inge
    Nortier, Johan W. R.
    Zonderland, Harmien M.
    van de Velde, Cornelis J. H.
    ACTA ONCOLOGICA, 2015, 54 (03) : 349 - 360
  • [36] Mutational Analysis of PI3K/AKT Signaling Pathway in Tamoxifen Exemestane Adjuvant Multinational Pathology Study
    Sabine, Vicky S.
    Crozier, Cheryl
    Brookes, Cassandra L.
    Drake, Camilla
    Piper, Tammy
    van de Velde, Cornelis J. H.
    Hasenburg, Annette
    Kieback, Dirk G.
    Markopoulos, Christos
    Dirix, Luc
    Seynaeve, Caroline
    Rea, Daniel W.
    Bartlett, John M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2951 - +
  • [37] Elderly Postmenopausal Patients With Breast Cancer Are at Increased Risk for Distant Recurrence: A Tamoxifen Exemestane Adjuvant Multinational Study Analysis
    van de Water, Willemien
    Seynaeve, Caroline
    Bastiaannet, Esther
    Markopoulos, Christos
    Jones, Steve E.
    Rea, Daniel
    Hasenburg, Annette
    Putter, Hein
    Hille, Elysee T. M.
    Paridaens, Robert
    de Craen, Anton J. M.
    Westendorp, Rudi G. J.
    van de Velde, Cornelis J. H.
    Liefers, Gerrit-Jan
    ONCOLOGIST, 2013, 18 (01): : 8 - 13
  • [38] EFFECTS OF EXEMESTANE AND TAMOXIFEN TREATMENTS ON BONE QUANTITY AND QUALITY IN PATIENT WITH BREAST CANCER
    Hadji, P.
    Kalder, M.
    Kauka, A.
    Bauer, M.
    Ziller, M.
    Hans, D.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S289 - S290
  • [39] Patterns of care in patients included in the TEAM (tamoxifen and exemestane adjuvant multicentre) trial. Differences among the participating countries.
    van de Velde, CJ
    Jones, SE
    Seynaeve, C
    Namer, M
    Kieback, DG
    Rea, DW
    Dirix, D
    Markopoulos, C
    Hozumi, Y
    van Nes, JG
    Kranenburg, WMK
    Putter, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S143 - S144
  • [40] Physical activity to maintain quality of life in breast cancer survivors in the Dutch Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial.
    Voskuil, D. W.
    van Nes, J. G.
    Junggeburt, J. M.
    van Leeuwen, F. E.
    van de Velde, C. J.
    de Haes, H. C.
    CANCER RESEARCH, 2009, 69 (02) : 277S - 277S
12345